Pituitary neuroadenolysis was performed 136 times on 102 terminally ill patients with intractable cancer pain. Through the aid of televised fluoroscopy, one or two needles were inserted manually through a nostril into the sella turcica, and 1.0-2.4 ml of pure ethanol was instilled. Excellent relief of cancer pain was ultimately obtained almost instantaneously in 82 (80%) out of 102 cases; 95% in 43 cases with hormone-dependent tumors and 69% in 59 cases with non-hormone-dependent tumors. In some cases, pain relief continued over a period of more than 2 years.<BR> Tumor regression was also observed in three cases (6.9%) with carcinoma of the breast and prostate gland. Visual field defects were complained of in 10 cases, and temporary ophthalmoplegia was observed in four. Diabetes insipidus was documented in half of the cases. Euphoria and increased appetite were observed in most cases, which suggested hypothalamic involvement. There was no death ascribed to NALP. Transsphenoidal surgical hypophysectomy was also performed on 18 other cases with carcinoma of the breast and prostate gland. Cancer pain relief was obtained in 88% of 16 cases with intractable pain, and objective tumor regression was achieved in 55% out of 18 cases. Subsequent to surgery, diabetes insipidus (16 cases), mental changes (4 cases), cerebrospinal fluid rhinorrhea (4 cases), and meningitis (2 cases) were documented in the early postoperative stage. The operative mortality rate was 5.6%.
Introduction
The management of pain in terminally ill patients is one of the major problems in cancer treatment and nursing care. Moricca's pituitary neuroadenolysis (NALP) 13,14) was reported to result in immediate and long-lasting pain relief in almost all of the patients suffering from intractable cancer pain.2,6,7,9-11,13,14) Since March 1977, the authors have performed NALP on 102 patients with intractable pain caused by disseminated cancer metastases from various origins, and surgical hypophysectomy on 18 patients with disseminated breast and prostate carcinomas. The Patients Treated I. NALP (Table 1) The 102 patients who received NALP were suffering from intractable pain caused by hormone-dependent (43 cases) and non-hormone-dependent (59 cases) malignant neoplasms as shown in Table 1 . The age of the patients ranged from 14 to 81 years. There were 57 males and 45 females. In the majority of the cases, the diseases were at advanced stages. Disseminated bone Table 2) . All of the patients had been ineffectively treated with pentazocine, morphine, and/or continuous epidural spinal block with lidocaine solution. NALP was performed 136 times on the 102 patients. II. Surgical hypophysectomy (Table 3) Eighteen patients subjected to surgical hypophy sectomy suffered from disseminated breast (17 cases) and prostatic (1 case) carcinomas. The surgery was often indicated in cases which showed a good systemic condition, based on the clinical results of previous endocrine therapies, L-DOPA test, estrogen-receptor assay of the tumor tissues, and the preference of the patient and/or family. The age of the patients ranged from 35 to 66 years. There were 17 females and one male (prostate). Disseminated bone metastases were observed in 15 patients, all of whom complained of intractable pain. The sites of the pain are shown in Table 2 the 16 gauge one was placed through the 16 gauge needle instead of the stilette. With the help of TV monitoring, the 19 gauge needle was hammered in and was easily introduced into the sellar cavity. Gentle suction with a syringe was enough to preclude the possibility of bleeding and cerebrospinal fluid leakage. Pure ethanol was then instilled very slowly. Usually, one or two needles were inserted through a nostril with the tips approximately to the midline of the sella turcica (Fig. 1) . Instillation of ethanol through a single needle with the tip reaching almost to the posterior wall of the sella turcica was often enough to provide pituitary inactivation. The total amount of instilled ethanol ranged from 1.0 to 2.4 ml, and 2.0 ml was the amount most frequently instilled. Five minutes after, the needle was withdrawn, and the nasal cavity was often packed to avoid epistaxis. Extraocular movement and pupillary reaction to light was checked during this performance. For this purpose, the ethanol instillation was often performed after the patient awoke from anesthesia. The puncture needle devised by the authors consisted of a 16 and 19 gauge needle (Fig. 2) , each with a stilette. The 16 gauge needle with stilette was used to reach the outer surface of the sellar floor and the 19 gauge needle with stilette was used to penetrate it. Insertion of the 19 gauge needle through the 16 gauge needle, in place of its stilette, allowed the tip of the 19 gauge needle to protrude 5 to 8 mm from the tip of the 16 gauge needle, safely limiting the depth of the pituitary puncture. Hence, the hole made by the puncture at the sellar floor was small enough to prevent leakage of the cerebrospinal fluid.
II.
Surgical hypophysectomy
Surgical hypophysectomy was carried out through the subnasal rhinoseptal transsphenoidal approach under televised fluoroscopic control using an operative microscope .5) General anesthesia was always employed.
The pituitary gland was totally removed with a low stalk section. Before the use of NALP, the grade of cancer pain in the 102 patients ranged from Grade 3 to 4, with a mean value of 3.6. Pain relief through initial performance of NALP (Fig. 3) . Ethanol instillation was performed in 101 of the 102 patients. In one patient, repeated punctures of the sella turcica caused cerebrospinal fluid outflow from the needle, indicating an empty sella, and ethanol instillation was abandoned.
In 81 out of 101 patients, complete pain relief follow ing initial ethanol instillation, reaching Grades 0 and 1 over a week, was obtained and lasted for a period up to 18 months. Cancer pain was commonly alleviated to a level of excellence in resting patients, but was sometimes induced by physical movement. Simul taneous non-cancer pain did not respond to treatment. Naloxone (0.8 mg) was given to one patient several days after complete relief had been achieved, without reversing cancer pain. In 31 of the 81 patients, pain recurred after an interval ranging from 7 to 170 days, 34 days on the average (median value, 14 days). A second performance of NALP was often chosen by the patients.
In 11 out of 101 patients, the initial NALP resulted in incomplete pain relief in which the pain decreased in grade, but remained at Grade 2. Five of the patients were satisfied. The other six chose to be subjected to a second NALP, 9-89 days after the initial procedure.
The other nine patients did not respond to treatment. A second NALP was performed on 7 of them 2-7 days after the initial NALP. In one patient with prostatic carcinoma, pain was completely relieved by NALP, but a second NALP was performed 3 weeks later to complete pituitary inactivation.
Pain relief through the second NALP (Fig. 3) : The second NALP, performed on 19 patients for recurring pain, resulted in complete relief in 16 cases and in complete relief in three. Complete relief persisted for a long period of up to 48 months. Pain recurred again in 4 of the patients 10-180 days afterwards, and a third NALP was carried out in two cases, resulting in complete relief in one, and incomplete relief in the other.
A second NALP, performed on six patients who obtained incomplete relief through the initial NALP, resulted in complete pain relief in two patients and incomplete relief in the other four.
In 7 out of 9 cases in which the initial NALP failed to relieve the pain, a second NALP was performed. It resulted in complete relief in one case with breast cancer, incomplete relief in another case with gastric cancer, and failed to relieve pain in five patients. In some of them, even a third NALP failed to relieve pain.
Ultimate results of pain relief through NALP : Out of a total of 102 patients, 82 (80 %) eventually obtained complete pain relief (Table 1) . Incomplete relief was documented in 10 (10%), and failure to obtain relief was noted in 10 (10%). In 43 cases with hormone dependent tumors (breast, prostatic, and thyroid carcinomas), complete pain relief was obtained in 41 (95%). In 59 non-hormone-dependent tumors, com plete relief was obtained in 41 (69 %).
The long-term follow-up results are shown in Fig. 4 . The obtainability of complete pain relief (100 x No. of cases with complete pain relief/No. of survivors) was of the order of 70 % after 1 week to 12 years after the initial NALP (Table 4, Fig. 4) .
Three patients are now surviving and are still pain free. Four patients survived pain-free for more than 2 years. The person who survived the longest was a 38 year-old female with breast cancer, who had been subjected to NALP twice. She has no complaints and is pain-free now, 4 years and 6 months after the initial NALP, and no new metastatic foci have been detected. Tumor regression: NALP resulted in tumor regres sion in 3 (6.9 %) out of 43 cases with hormone dependent carcinomas. Metastatic foci decreased in size in 2 cases with breast carcinoma, and a pathological fracture was fused in a case with prostatic carcinoma (Fig. 5) . Following NALP, elevated serum acid phosphatase concentration often decreased in cases with bone metastases from prostatic carcinoma.
Side effects (Table 5) : Half of the patients com plained of headaches, but the headaches had disap peared by the next morning. Almost 2 days after NALP, euphoric states and increased appetites were temporarily observed in most patients, and these continued for several days. In the same period, hyperthermia were also observed in a few cases and a few patients had hallucinations. Endocrinological crises due to anterior pituitary dysfunction was thoroughly prevented by administration of hydro cortisone. Polyuria or diabetes insipidus occurred after 69 NALP performances and disappeared by approxi mately the 14th day after NALP performance.
Complications (Table 5) : No death was ascribed to performance of NALP. Visual field defects were com plicated in 10 cases. 2.4 ml of ethanol, the maximum dose in our series, was instilled in four cases, and in 2 of the cases the patients complained of visual field defects. Unilateral ophthalmoplegia was temporarily observed in three cases, and spontaneously disappeared 10 days later. Meningitis was observed in two aged patients. Cerebrospinal fluid rhinorrhea was observed for several days in one case following the performance of NALP. II. Surgical hypophysectomy Pain relief: Pain relief was obtained in 15 out of 17 patients with intractable pain when they awoke from anesthesia (Table 2) . Pain relief was complete (Grade 0) in all of the 15 patients whether tumor regression was obtained or not, and lasted for a period ranging from 2 to 36 months. In 4 of the patients, pain recurred 2-36 months after, and the patients were further treated with analgesic medications. The long term follow-up results revealed that two patients are now alive and pain-free. The patient who has survived the longest is a female with breast carcinoma metastasizing to the pelvis, which has calcified. She is still alive, 5 years and 6 months after the surgery.
Tumor regression: Surgical hypophysectomy resulted in tumor regression in 10 (55.5 %) out of 18 cases. Metastatic foci decreased in size (Fig. 6) , and recalcification of osteolytic bone metastasis was also observed. Of these 10 patients, seven were able to enjoy their daily life for more than 6 months.
Side effects (Table 5) : Following surgical hypophy sectomy, headaches were uncommon, but euphoria was common. Several days after the surgery, mental changes such as hallucinations and confusion were sometimes observed temporarily. Diabetes insipidus developed in 16 cases within 24 hours following surgery and continued for 4-6 months. Endocrinological crises were thoroughly prevented by administration of hydrocortisone.
Complications (Table 5) : Cerebrospinal fluid rhinor rhea was the most frequent complication and was documented in four cases, and in 2 of these meningitis resulted. Cerebrospinal fluid rhinorrhea was repaired by sealing the sellar floor with Biobond® injected into the sphenoidal sinus utilizing the NALP needle. There were no ocular complications. The operative mortality rate was 5.6 %. A female with breast carcinoma died of subarachnoid hemorrhage 2 days after the surgery.
Discussion
Frequent alleviation of intractable cancer pain in disseminated breast carcinoma following hypophy sectomy prompted Moricca to establish a new procedure to ablate the pituitary gland. 13 ,14) Initially, he tried to inject alcohol into the sella turcica to relieve cancer pain in hormone-dependent tumors; later, he also obtained an excellent alleviation of cancer pain in non-hormone-dependent tumors. His results were mostly supported by Katz and Levin,6°') Levin et al.,') Lipton et al.,",") and Corssen et al.') In this paper, the clinical results of NALP and surgical hypo physectomy are comparably described; both procedures have been carried out by the same operator. The results of pain relief by NALP are not as excellent as those reported by Moricca who repeats NALP even four times until cancer pain relief is achieved.") NALP is a procedure of chemical ablation of the pituitary gland. It has some side effects which may unavoidably occur following pituitary intervention. There are also some complications which have to be avoided. In order to reduce the side effects and to prevent the complications (Table 5) , several modifications have been made by the authors in the technical aspect of NALP and in its posttreatment management.
Our technique of instillation of ethanol into the sella turcica is essentially based on Moricca's manual 13) procedure. With a large bore needle, it is easy to gain access to the pituitary gland beyond bony structure, but so large a hole is made at the sellar floor that it must be sealed with alpha-ethyl cyanoacrylate to prevent cerebrospinal fluid leakage.') A smaller bore needle makes a smaller hole, but often bends before penetrating the sellar floor. If the needle is directed too laterally, injury of the oculomotor and/or abducens nerve can result. The tip of the needle should be placed along the midline of the sella turcica. The manual technique we devised utilizing a puncture needle renders the pituitary puncture safe and correct, and the time it consumes is shorter than with the procedure under stereotactic control.',')
The total amount of ethanol to be injected varies according to the literature. Moricca reported using an amount ranging from 0.6 to 2.0 ml,",") or more. 15) Katz and Levin6) injected 5-6 ml of ethanol. An excessive amount of ethanol can enhance danger of chemical injury to the optic chiasm. Our results, obtained from Japanese patients, indicate that less than 2 ml would be appropriate; however, less than 1.8 ml of ethanol is more likely to result in incomplete relief and recurrence of pain especially in non-hormone dependent tumors; 2.4 ml or more may induce visual field defects. Another way to avoid ocular complication is to instill ethanol very gently or slowly. Moriccal5> performs pituitary puncture under general anesthesia, and injects alcohol after the patient has completely awoke from the anesthesia to avoid ocular complica tions. Moricca15) also indicates that when visual field defects are complicated, a cisternal puncture should be promptly indicated to remove more than 10 ml of cerebrospinal fluid and to instill predonisolone into the cistern. The authors experienced a case in which hemianopsia was immediately relieved by performance of this procedure.
Surgical hypophysectomy via the transsphenoidal approach') is more complicated and more time consuming than NALP. It is a major and traumatic intervention (Table 6) .
Hormone replacement therapy is necessary to counter pituitary dysfunction after pituitary ablation. After performance of NALP, such therapy is tem porarily necessary until clinical and endocrinical assessments guarantee that there will be no endocrino logical crisis. After surgical hypophysectomy, replace ment therapy is given throughout the patient's life. Diabetes insipidus is the most usual hazard following pituitary ablation.
Excessive urinary excretion would be intolerable for terminally ill patients. A reasonable and effective method to reduce the urinary volume in polyuria without any significant side effect is successfully carried out with rectal insertion of indomethacine suppository. It reduces polyuria by suppressing renal prostaglandin E2 which interferes with inactivation of ADH, and does not disturb the diurnal pattern of urinary excre tion in polyuria. Details are mentioned elsewhere.') Euphoria and polyphagia, the main clinical manifesta tions of the hypothalamic involvement of NALP, are rather favorable to patients with terminal diseases.
NALP has resulted in excellent relief of cancer pain in 80 % of the total cases in this series: 95 % of the cases with hormone-dependent tumors, and 69% with non-hormone-dependent tumors. It has particular advantages in terms of simplicity and brevity of proce dure, repeatability in the case of pain recurrence, and short hospital stay.') It is possible to safely perform NALP on high-risk patients, and, as stated by Corssen et al.,') it had an excellent rate of acceptance by patients, and minimal posttreatment discomforts (Table 6 ). These advantages render the indications for NALP more favorable than those for surgical hypo physectomy in relief of intractable pain in disseminated malignant tumors, both hormone-dependent and non dependent. Though not as frequently as in cases treated with surgical hypophysectomy, tumor regression was observed after NALP in some cases with breast and prostatic carcinomas. Surgical hypophysectomy, a more complicated technique with more postoperative hazards than NALP (Table 6 ) can result in equally excellent pain relief in breast and prostatic carci nomas, 1,s 1,8,12,18) and is reported to frequently relieve cancer pain in non-hormone-dependent tumors. 17) Cryohypophysectomy was effectively carried out on cases with breast cancer to relieve the bone pain.") Thus, pituitary ablation by various techniques is frequently effective in obtaining cancer pain relief, and, at the same time, tumor regression is obtained in some cases with hormone-dependent carcinomas. Surgical hypophysectomy shows an excellent rate of tumor regression in breast carcinoma.' ,12) The authors prefer NALP to relieve cancer pain, both in hormone dependent and non-dependent tumors, and surgical hypophysectomy when the aim of the treatment is to achieve tumor regression. Surgical hypophysectomy is not indicated in high-risk patients. 
